Fluorotechnics 2H Revenues Slide 32 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian fluorescence and protein detection technologies firm Fluorotechnics, which is undergoing a restructuring, reported that revenues for the second half of 2010 fell 32 percent year over year to A$1.3 million ($1.3 million) from A$1.8 million.

For the six months ended Dec. 31, 2010, sales to external customers shrank to A$1.2 million, a 33 percent drop-off from $1.8 million a year ago, while other revenues nearly doubled to A$144,341 from A$73,040.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.